January 24, 2012 – Global precision marketing platform company Adara Media Inc. has secured $12.4 million in funding from venture capital firm August Capital, with participation from returning investors ONSET Ventures, Morgenthaler Ventures, and Baseline Ventures.
January 23, 2012 – VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices for the treatment of end-stage age-related macular degeneration (AMD), today announced the closing of expansion of the Series E financing, with Agate Medical Investments leading the expansion round. Agate’s Managing General Partner, Chanan Schneider, will join the VisionCare team as [...]
January 9, 2012 – Uptake Medical® today announced that it has closed on a Series C funding round.
Early Stage Partners, Onset Ventures and Capital Midwest Fund Co-Lead Funding for Company Focused on Addressing Acute Kidney Injury ANN ARBOR, MICHIGAN – January 4, 2012 – CytoPherx, Inc. today announced it has completed a $34 million round of funding. A large syndicate of investors co-led by Early Stage Partners, ONSET Ventures and Capital Midwest [...]
December 8, 2011 – Adara Media Inc., a global travel marketing platform company, today announced that its TruPrecision Targeting Platform has been named the Best Vendor Ancillary Revenue Merchandising in the Mega Awards, hosted by Airline Information.
November 29, 2011 – Uptake Medical today announced the first commercial use of the InterVapor™ System for endoscopic lung volume reduction in a patient with severe emphysema.
November 10, 2011: VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic devices, today announced that the first patient has received the FDA-approved Implantable Miniature Telescope (by Dr. Isaac Lipshitz) procedure indicated to improve vision in patients with end-stage age-related macular degeneration (AMD).
REDWOOD CITY, Calif., Oct. 31, 2011 – Relievant MedSystems Inc. today announced the company has enrolled the first patient in its SMART trial to evaluate the Intracept® Basivertebral Nerve Ablation Procedure. The Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain (SMART) trial is a Level 1, prospective, randomized, double-blind, sham-controlled [...]